Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 2
1996 1
2000 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
Nomenclature for N-acetyltransferases.
Vatsis KP, Weber WW, Bell DA, Dupret JM, Evans DA, Grant DM, Hein DW, Lin HJ, Meyer UA, Relling MV, et al. Vatsis KP, et al. Pharmacogenetics. 1995 Feb;5(1):1-17. doi: 10.1097/00008571-199502000-00001. Pharmacogenetics. 1995. PMID: 7773298 Review.
Inhibition of human red blood cell N-acetyltransferase.
Voice RA, Manis M, Weber WW. Voice RA, et al. Drug Metab Dispos. 1993 Jan-Feb;21(1):181-3. Drug Metab Dispos. 1993. PMID: 8095216
Slow acetylation in mice is caused by a labile and catalytically impaired mutant N-acetyltransferase (NAT2 9).
De Leon JH, Martell KJ, Vatsis KP, Weber WW. De Leon JH, et al. Drug Metab Dispos. 1995 Dec;23(12):1354-61. Drug Metab Dispos. 1995. PMID: 8689943
Tissue- and gender-specific expression of N-acetyltransferase 2 (Nat2*) during development of the outbred mouse strain CD-1.
Estrada L, Kanelakis KC, Levy GN, Weber WW. Estrada L, et al. Drug Metab Dispos. 2000 Feb;28(2):139-46. Drug Metab Dispos. 2000. PMID: 10640510
Effects of heredity on response to drugs and environmental chemicals: construction of rodent models.
Levy GN, Rodgers L, Weber WW. Levy GN, et al. Chem Res Toxicol. 1996 Dec;9(8):1215-24. doi: 10.1021/tx960082y. Chem Res Toxicol. 1996. PMID: 8951222 Review. No abstract available.
Characterization of naturally occurring and recombinant human N-acetyltransferase variants encoded by NAT1.
de León JH, Vatsis KP, Weber WW. de León JH, et al. Mol Pharmacol. 2000 Aug;58(2):288-99. doi: 10.1124/mol.58.2.288. Mol Pharmacol. 2000. PMID: 10908296